Jiangsu Hengrui Pharmaceuticals Co Ltd
-
Retagliptin Phosphate Tablets approved by China NMPA for type 2 diabetes
Jun,2023. Retagliptin Phosphate Tablets, the Class 1. New drug from Jiangsu Hengrui Pharmaceuticals Co., Ltd for the treatment of type 2 diabetes, is approved by China NMPA.
